Medicare Part D Spending for Hepatitis B Virus Drugs: Completing the Picture and Extending the Dataset

Gastroenterology. 2024 Feb;166(2):359-360. doi: 10.1053/j.gastro.2023.08.012. Epub 2023 Aug 17.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aged
  • Drug Costs
  • Health Expenditures
  • Hepatitis B virus / genetics
  • Humans
  • Medicare Part B*
  • Medicare Part D*
  • United States